DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
License: Public Domain

Roswell Park Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, blasts 30 percent or less of bone marrow nucleated cells, chronic myelomonocytic leukemia, high risk myelodysplastic syndrome, myelodysplastic syndrome, refractory anemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136397
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.